University Hospital Leipzig, Germany
Professor Thomas Berg is Head of the Department of Gastroenterology and Rheumatology – Section Hepatology at the University Hospital Leipzig (Germany).
Erasmus Medical Centre, Rotterdam, The Netherlands
He received his training at the Academic Medical Centre in Amsterdam under the supervision of Prof. dr. Guido Tytgat and Prof. dr. Kees Huibregtse. His clinical and research activities focus on gastrointestinal oncology, hepato-pancreato-biliary diseases and interventional endoscopy, including endoscopic retrograde cholangio¬pancreatography (ERCP) and endoscopic ultrasound (EUS). He (co)-author of numerous peer reviewed articles in high ranking journals including the New England Journal of Medicine. He is a recognized international authority on the diagnosis and treatment of pancreatic diseases and has served as invited faculty at many international conferences and live endoscopy workshops. He is chairman of the Dutch Pancreatitis Study Group, council member end treasurer of the European Association of Gastroenterology, Endoscopy & Nutrition (EAGEN), and past council member and chairman of the Education Committee of United European Gastroenterology (UEG).
The Erasmus Medical Center is a large tertiary care 1320 bed academic hospital located in the city of Rotterdam the Netherlands. The department of Gastroenterology & Hepatology employs 16 staff members covering all the relevant GI & H specialty areas including hepatology (hepatitis, hepatocellular carcinoma, and liver transplantation), advanced endoscopy, GI oncology (esophageal, stomach, pancreas and colon), and inflammatory bowel disease and intestinal ischemia. The department has 16 fellows in training to become gastroenterologists and 2 foreign fellows for advanced endoscopy training. The department has its own dedicated laboratory facilities for translational and basic research. In total, 40 PhD students are working in the department to complete their PhD thesis on clinical, translational and basic research topics covering the various focus areas of the department.
Gustave Roussy, University of Paris Saclay, France
Professor Ducreux trained in medicine, gastroenterology, and gastrointestinal tract oncology at the University of Paris Sud, and holds a masters degree in biological sciences and a PhD in health sciences. He has held positions as assistant physician and professor of oncology at the Gastrointestinal Unit of Gustave Roussy and Paul Brousse Hospital in Villejuif. He became medical affairs director of Gustave Roussy in January 2011. He is the former chair of the European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group, and is the former chair of the Gastrointestinal Group of the French Federation of Anticancer Centers (FNCLCC). He is co-editor for GI oncology of the European Journal of Cancer.
Professor Ducreux has published more than 430 scientific articles, with papers for which he was lead author, focussing on the management of metastatic colorectal cancer, locally advanced and metastatic pancreatic carcinoma, biliary tract carcinoma, hepatocellular carcinoma, and treatment of neuroendocrine tumors. Further to this, Professor Ducreux is author to over 150 invited lectures in various national and international congresses.
Maria-Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Michal F. Kaminski is a graduate of the Medical University of Warsaw, Poland and now is Head of the Department of Cancer Prevention and Head of Endoscopy Unit in the Department of Gastroenterological Oncology, at the Maria-Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. He is also appointed at the Medical Center for Postgraduate Education, Warsaw, Poland and Institute of Health and Society, Oslo, Norway.
Most of his time he dedicates to research and education in the field of quality of endoscopy, endoscopic treatment of early GI neoplasia and colorectal cancer screening.
In consequence he is Co-Head of the Polish Colonoscopy Screening Programme, Head of the Quality Section of Polish Society of Gastroenterology and Councillor in the European Society of Gastrointestinal Endoscopy. He is also Chairman of the Warsaw Live Endoscopy Workshop.
He serves as Co-PI for the NordICC study (the Nordic-European Initiative on Colorectal Cancer) and member of the Scientific Board of the EPoS study (European Polyp Surveillance trial) and Co-PI of the Polish Colonoscopy Screening Platform Study, which are key European trials in the field of colorectal cancer prevention. He is in the international editorial boards of Lancet Gastroenterology and Hepatology, Gastrointestinal Endoscopy and Endoscopy journals.
Otto v. Guericke University, Magdeburg, Germany
He received his MD from the University of Bologna, Italy in 1975, and gained subsequent medical experience at the Regional Hospital of Bozen, Italy, and the University Hospital of Ulm, Germany (1978-1992), a Research Fellow at the Mayo Clinic GI Unit in Rochester, MN, USA. Professor Malfertheiner has been Chairman of the UEGF (2004) and President of the UEGW 2006 and of the Education Committee of the United European Gastroenterology Federation (UEGF). He is also the Editor of Digestive Diseases, Associate Editor of the American Journal of Gastroenterology, and a member of the Editorial Boards of several other journals; the European Journal of Gastroenterology, Helicobacter, Digestive Surgery, and the International Journal of Pancreatology. His main research interests are Helicobacter pylori infection and related diseases, chronic inflammation and carcinogenesis, gastric cancer, hepatocellular cancer, gastroesophageal reflux disease (GERD).
University Hospital KU Leuven, Belgium
A specialist in internal medicine, gastroenterology, and hepatology, he earned his medical degree from the Catholic University of Leuven as well as a PhD in the pathophysiology of esophageal varices. Current research interests include complications of cirrhosis, liver transplantation, and chronic hepatitis B and C viruses and polycystic liver disease. The author of more than 200 peer-reviewed manuscripts, Dr. Nevens is a board member of the Flemish Society of Gastroenterology and the Belgian Transplant Society, and is a member of the European and International Associations for the Study of the Liver and the American Association for the Study of Liver Diseases. He cofounded the Belgian Association of the Study of the Liver, and has served as an EASL board member and president of the Belgian Liver and Intestinal Transplantation Committee.
St. John of God Hospital, Regensburg, Germany
Department of Gastroenterology and Hepatology at the University of Zurich, Switzerland
Dr. Rogler received his medical degree from the University of Ulm, Germany, and doctoral degrees from the Universities of Augsburg and Ulm, Germany. He completed postdoctoral training at the Division of Gastroenterology at the University of Ulm and at the Institute of Clinical Chemistry at the University of Regensburg, Germany. He also completed a Heisenberg Fellowship with the German Science Foundation. He was appointed head of the Division of Gastroenterology and Hepatology at the University of Regensburg in 2002 and full chair of Gastroenterology and Hepatology at the University of Zurich in 2014.
Dr Rogler’s research interests focus on translational research to better understand unmet needs in the field of IBD, especially intestinal stricture and fistula formation. His group has developed new models for intestinal fibrosis and achieved a completely new understanding of fistula pathophysiology. Dr Rogler is principal investigator of the Swiss IBD cohort study, a nationwide cohort project currently supported by the Swiss National Science Foundation. He is a member of the International Organisation of IBD Research and on the governing board of the European Crohn’s and Colitis Organisation. He has authored hundreds of original peer-reviewed articles and received various awards and memberships, including honorary membership to the South African Society of Gastroenterology in 2013 and the LeVaillant Award in 2015. Dr Rogler is the co-founder of PharmaBiome, a start-up developing new technologies in microbiota therapy.
Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases, Metabolism and Ageing (ChroMetA), KU Leuven, Leuven, Belgium
Division of Gastroenterology and Hepatology, University Hospital Leuven, Leuven, Belgium
Leuven Intestinal Failure and Transplantation Center, University Hospital Leuven, Leuven, Belgium
Tim Vanuytsel currently holds a position as a consultant gastroenterologist in Leuven University Hospitals with a clinical focus on intestinal failure, clinical nutrition and functional gastrointestinal disorders. He is the co-founder and medical director of the Leuven Intestinal Failure and Transplantation center (LIFT), which is the largest intestinal failure center and the only small bowel and multivisceral transplant center in Belgium.
Tim Vanuytsel is an assistant professor at the University of Leuven and his research interests include the pathophysiology and treatment of functional gastrointestinal disorders and intestinal failure and transplantation. He has published >105 original research articles and reviews in international peer-reviewed journals on both clinical and basic science aspects of gastroenterology. He is the (co-)supervisor of 15 PhD students and 2 postdoctoral fellows. He is the editor in chief of Acta Gastroenterologica Belgica, associate editor of the GI section of Current Opinion in Pharmacology and member of the editorial board of Neurogastroenterology and Motility.